Skip to main content

NEUVIOR governance standard · 02

NEUVIOR Prescribing Service Accountability Standard

A NEUVIOR authored public governance principle. It is not a national, regulatory or certification standard. Use it to keep a professional prescribing decision distinct from the organisations and systems that deliver a service around it.

Published by NEUVIOR · 2 August 2026 · Version 1.0

Map the accountability chainExplore all standards
Document class | NEUVIOR governance principleAuthority | Professional and service roles remain distinctEvidence boundary | No prescribing, commissioning or outcome claim

The principle

Keep clinical authority and service accountability distinct.

Professional authority to prescribe and operational authority to deliver a commissioned service are related, but they are not interchangeable.

Applicable law, regulation, professional duties, mandatory standards and approved organisational arrangements prevail. Authority depends on the profession and role, including any required prescribing qualification or register annotation, current registration status, competence, scope and operating context. Prescribing rights are not transferable, and this principle does not grant them.

Human decision requiredProceed only inside an evidenced and governed scope.
01

Professional authority

The authorised professional remains accountable for their clinical decision within competence and scope.

Individual decision
02

Service authority

Commissioning, provider and governance organisations retain the duties attached to their roles.

Operating pathway
03

Technology responsibility

Developers, deployers and operators retain distinct responsibilities for the parts of the digital system they control.

System lifecycle

The accountability record

A governed prescribing based service should make clear:

Each responsibility should be named in the service’s own approved records before technology is treated as part of an operating pathway.

  • 01

    Professional decision

    who is professionally authorised to make the clinical decision;

  • 02

    Service approval

    which organisation approved the service and operating pathway;

  • 03

    Consultation information

    what information supports the consultation;

  • 04

    Decision record

    how referral, escalation and non prescribing decisions are recorded;

  • 05

    Digital responsibility

    who is responsible for the digital solution and its safe deployment;

  • 06

    Incidents and continuity

    how incidents, exceptions and continuity failures are managed; and

  • 07

    Operating review

    how quality, activity and outcomes are independently reviewed. The form and degree of independence should be proportionate to the risk.

Technology boundary

Technology can support the workflow. It cannot inherit the decision.

Technology may support the workflow. It does not replace the clinical judgement of an authorised professional or the accountability of the commissioning and provider organisations.

Technology organisations retain the responsibilities attached to the development, configuration, clinical risk management, deployment, use and maintenance activities they control. Prescribing, non prescribing, referral, escalation, safety netting, monitoring and follow up records remain part of the wider operating interpretation.

Publication does not determine whether a digital system is a medical device or which clinical safety requirements apply. Those questions require a context specific assessment.

This page provides general governance information, not legal, clinical or professional advice.

The GMC material linked below provides wider professional context. It does not endorse NEUVIOR or make this a professional prescribing standard.

Read the GMC’s wider prescribing context
01

Decision

An authorised professional assesses whether a safe clinical decision can be made and records what follows.

02

Pathway

The commissioning and provider organisations approve, govern and review the service within their responsibilities.

03

Digital system

The responsible organisations define intended use, controls, deployment, maintenance, incident and continuity arrangements.

Publication and evidence boundary

This principle grants no clinical or service authority.

This standard describes a governance principle. It does not indicate clinical efficacy, prescribing authority, NHS commissioning, deployment, regulatory approval or demonstrated patient outcomes.

Publication is not evidence that NEUVIOR has implemented, audited or independently validated this principle in a live service, and it does not establish medical device or clinical safety status.

Next: third party data responsibilityReview clinical governance
Human decision requiredProceed only inside an evidenced and governed scope.
01

Publisher

NEUVIOR

Publication owner
02

Revision history

Version 1.0 · Initial publication · 2 August 2026

Current public version
03

Review trigger

Material change in applicable law, professional guidance, clinical safety context, operating model or NEUVIOR’s public position.

Reassess and republish

Classified public record

Open the classified public record

ANALYSIS + EVIDENCE BOUNDARY

Read the argument. Verify the product separately.

Published analysis can explain why governance matters. It cannot evidence security, clinical authority, certification, product readiness or local approval. Use the dated NEUVIOR records for that.

  1. AI Ethics Now / University of Warwick IATLPodcast appearance

    AI and Accountability: When Does a Suggestion Become a Decision?

    Varun Sharma joins AI Ethics Now to examine false confidence, human responsibility and the point where AI assisted suggestions become accountable decisions.

    Hear where an AI suggestion becomes a decision
  2. TechRadar ProContributed opinion

    Five questions to test whether an AI stack is truly under your control

    In TechRadar Pro, Varun Sharma sets out five tests for enterprise AI control across provenance, infrastructure, legal authority and safe exit.

    Test provenance, control and safe exit
  3. NEUVIOR InsightsNEUVIOR analysis

    From pilot theatre to financial grip: how NHS CFOs should evaluate AI in medicines optimisation

    NHS finance leaders do not need another AI pitch. They need a disciplined way to decide whether a technology can release value within the financial rules they are already being held to.

    See how a finance leader should test an AI claim
Read the governance arguments

NEUVIOR Insights and After Publication reflections are company or founder analysis. Publisher records evidence publication, not endorsement, adoption, product readiness, savings or clinical outcomes.

The test

Can every decision be traced to the right kind of authority?

If professional judgement, service approval and digital responsibility have collapsed into one vague owner, the accountability record is incomplete.

Continue to third party responsibilityReturn to all standards

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01Does this standard give NEUVIOR or another person prescribing authority?

No. Prescribing authority depends on applicable law and the profession and role, including any required prescribing qualification or register annotation, current registration status, competence, scope and organisational arrangements. Prescribing rights are not transferable.

02Who remains accountable when technology supports prescribing?

The authorised professional remains accountable for their clinical decision. Commissioners, providers, developers, deploying organisations and operators retain the responsibilities attached to their separate roles.

03What happens when consultation information is incomplete?

The authorised professional must determine whether a safe decision can be made. Prescribing, a decision not to prescribe, referral, escalation, safety advice, monitoring and later review should be recorded where applicable.

04Does the standard determine whether software is a medical device?

No. That depends on the system’s intended purpose, functionality and operating context. It requires a separate assessment for the specific context.

05Does this describe a live prescribing service commissioned by the NHS?

No. It is a public governance principle, not evidence of clinical efficacy, prescribing authority, NHS commissioning, deployment, regulatory approval or demonstrated patient outcomes.